Canada · Federal contract register · Contract
Pharmaceutical and other medicinal products — Canada · Federal contract register · Contract: $18.6M contract value ($18,624,862); No competition how it was bought (Advance Contract Award Notice: one supplier named in advance); 2026 contract date (26 February 2026).
Assay record ASY-CA-02SX7YZ0NX · Cite as: Assay Systems, “Pharmaceutical and other medicinal products · National Defence · Emergent Biosolutions Canada Inc”, https://assay-systems.com/register/ca/contract/c-2025-2026-q4-02254/
| Department | National Defence |
|---|---|
| Supplier | Emergent Biosolutions Canada Inc |
| Contract date | 26 February 2026 |
| Period | 26 February 2026 – 31 March 2033 |
| Value | $18,624,862 |
| Procedure | Non-competitive (Advance Contract Award Notice: one supplier named in advance) |
| Bids received | not stated |
| Economic object code | 1132 |
The department awarded it without a competition. Emergent Biosolutions Canada Inc took $18,624,862 with no other bid on the table.
Proactive disclosure of contracts over $10,000, Government of Canada, open.canada.ca, under the Open Government Licence – Canada. Where a contract was amended, the page carries the last report filed for it.
Contains information licensed under the Open Government Licence – Canada.Source: Government of Canada proactive disclosure of contracts.